000 01964cam a2200505Mi 4500
001 vtls003274859
003 MY-SjTCS
005 20200508125119.0
006 m o d
007 cr u| ---a||||
008 171218s2012 ne a ob 001 0 eng d
010 _z2011-294197
020 _z0123919118
020 _z9780123919113
020 _a9780128042588
020 _a0128042583
020 _a0123919134
020 _a9780123919137
035 _a(OCoLC)988815581
_z(OCoLC)830350770
_z(OCoLC)1011245609
035 _a(OCoLC)ocn988815581
039 9 _a201712181426
_bshuhada
_y201712181209
_zshuhada
040 _aZ5A
_beng
_erda
_cZ5A
_dMNU
_dN
_dOCLCF
_dYDXCP
_dTEFOD
_dOCLCO
_dCASUM
_dOCLCO
049 _aMAIN
060 0 0 _a2012 F-200
060 1 0 _aQV 771
_bC64195 2012
082 0 4 _a610.724
_223
100 1 _aBrody, Tom,
_eauthor.
_960555
245 1 0 _aClinical trials :
_bstudy design, endpoints and biomarkers, drug safety, FDA and ICH guidelines /
_cTom Brody.
250 _aFirst edition.
264 1 _aAmsterdam :
_bElsevier/AP,
_c2012.
300 _a1 online resource (xxxiii, 638 pages) :
_billustrations.
336 _atext
_2rdacontent
337 _acomputer
_2rdamedia
338 _aonline resource
_2rdacarrier
504 _aIncludes bibliographical references and index.
588 _aMachine converted from AACR2 source record.
588 _aBased on print version record.
590 _aeBooks on EBSCOhost
_bAll EBSCO eBooks
650 0 _aClinical trials.
_924193
650 0 _aDrug approval.
_962141
655 4 _aElectronic books.
776 0 8 _iPrint version:
_aBrody, Tom.
_tClinical trials
_a1st ed.
_dAmsterdam : Elsevier/AP, 2012.
_w2011294197
_w(OCoLC)772582481
_z9780123919113
830 0 _aClinicalKey.
856 4 0 _uhttps://ezproxy.taylors.edu.my/login?url=http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1158706
_zAn electronic book accessible through the World Wide Web; click to view
999 _c130817
_d130817